Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

Sanofi has entered into an agreement to acquire Vigil Neuroscience Inc., a publicly traded clinical-stage biotechnology ...

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...

The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.

There have been a growing number of drug products approved that look to target the brain following intranasal delivery.

Waters Corp. has acquired Halo Labs, a company specialized in imaging technologies to detect, identify, and count interfering ...

Inhaled therapeutics is an area of the pharmaceutical industry that is in high demand and is set for continued growth in the ...

Oral solid dosage forms such as tablets and capsules remain the most widely used method for delivering drug products to ...

The nasal route offers a number of benefits over some of the traditional routes of administration for biologics.

Interest in developing nasal dosage forms has increased significantly in the last two years, driven by a number of recent ...